Third, we found that αSyn co-pathology was related to faster AD-related cognitive decline, which was potentially driven by faster tau accumulation in αSyn SAA positive individuals on the AD spectrum (i.e. amyloid-PET positive). This evidence concerns the gene MAPT and Alzheimer disease.